Package 17856-0631-1

Brand: atovaquone

Generic: atovaquone
NDC Package

Package Facts

Identity

Package NDC 17856-0631-1
Digits Only 1785606311
Product NDC 17856-0631
Product ID 17856-0631_34f352d5-bdca-df12-e063-6294a90a54bd
Description

72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0631-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0631-2)

Marketing

Marketing Status
Marketed Since 2024-09-04
Brand atovaquone
Generic atovaquone
Sample Package No

Linked Drug Pages (1)

Atovaquone ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "34f352d5-bdca-df12-e063-6294a90a54bd", "openfda": {"nui": ["N0000175482", "N0000175485"], "unii": ["Y883P1Z2LT"], "rxcui": ["308429"], "spl_set_id": ["f99a8a0c-2b42-4da0-8f5a-e963fc619e8b"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [{"sample": false, "description": "72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0631-1)  / 5 mL in 1 CUP, UNIT-DOSE (17856-0631-2)", "package_ndc": "17856-0631-1", "marketing_start_date": "20240904"}], "brand_name": "Atovaquone", "product_id": "17856-0631_34f352d5-bdca-df12-e063-6294a90a54bd", "dosage_form": "SUSPENSION", "pharm_class": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "product_ndc": "17856-0631", "generic_name": "Atovaquone", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atovaquone", "active_ingredients": [{"name": "ATOVAQUONE", "strength": "750 mg/5mL"}], "application_number": "ANDA210692", "marketing_category": "ANDA", "marketing_start_date": "20181011", "listing_expiration_date": "20261231"}